Cargando…
Phenome-driven disease genetics prediction toward drug discovery
Motivation: Discerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542779/ https://www.ncbi.nlm.nih.gov/pubmed/26072493 http://dx.doi.org/10.1093/bioinformatics/btv245 |
_version_ | 1782386561327824896 |
---|---|
author | Chen, Yang Li, Li Zhang, Guo-Qiang Xu, Rong |
author_facet | Chen, Yang Li, Li Zhang, Guo-Qiang Xu, Rong |
author_sort | Chen, Yang |
collection | PubMed |
description | Motivation: Discerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease gene discovery. However, most current studies used only one data source of human disease phenotype. We present an innovative and generic strategy for combining multiple different data sources of human disease phenotype and predicting disease-associated genes from integrated phenotypic and genomic data. Results: To demonstrate our approach, we explored a new phenotype database from biomedical ontologies and constructed Disease Manifestation Network (DMN). We combined DMN with mimMiner, which was a widely used phenotype database in disease gene prediction studies. Our approach achieved significantly improved performance over a baseline method, which used only one phenotype data source. In the leave-one-out cross-validation and de novo gene prediction analysis, our approach achieved the area under the curves of 90.7% and 90.3%, which are significantly higher than 84.2% (P < e(−4)) and 81.3% (P < e(−12)) for the baseline approach. We further demonstrated that our predicted genes have the translational potential in drug discovery. We used Crohn’s disease as an example and ranked the candidate drugs based on the rank of drug targets. Our gene prediction approach prioritized druggable genes that are likely to be associated with Crohn’s disease pathogenesis, and our rank of candidate drugs successfully prioritized the Food and Drug Administration-approved drugs for Crohn’s disease. We also found literature evidence to support a number of drugs among the top 200 candidates. In summary, we demonstrated that a novel strategy combining unique disease phenotype data with system approaches can lead to rapid drug discovery. Availability and implementation: nlp.case.edu/public/data/DMN Contact: rxx@case.edu |
format | Online Article Text |
id | pubmed-4542779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45427792015-08-25 Phenome-driven disease genetics prediction toward drug discovery Chen, Yang Li, Li Zhang, Guo-Qiang Xu, Rong Bioinformatics Ismb/Eccb 2015 Proceedings Papers Committee July 10 to July 14, 2015, Dublin, Ireland Motivation: Discerning genetic contributions to diseases not only enhances our understanding of disease mechanisms, but also leads to translational opportunities for drug discovery. Recent computational approaches incorporate disease phenotypic similarities to improve the prediction power of disease gene discovery. However, most current studies used only one data source of human disease phenotype. We present an innovative and generic strategy for combining multiple different data sources of human disease phenotype and predicting disease-associated genes from integrated phenotypic and genomic data. Results: To demonstrate our approach, we explored a new phenotype database from biomedical ontologies and constructed Disease Manifestation Network (DMN). We combined DMN with mimMiner, which was a widely used phenotype database in disease gene prediction studies. Our approach achieved significantly improved performance over a baseline method, which used only one phenotype data source. In the leave-one-out cross-validation and de novo gene prediction analysis, our approach achieved the area under the curves of 90.7% and 90.3%, which are significantly higher than 84.2% (P < e(−4)) and 81.3% (P < e(−12)) for the baseline approach. We further demonstrated that our predicted genes have the translational potential in drug discovery. We used Crohn’s disease as an example and ranked the candidate drugs based on the rank of drug targets. Our gene prediction approach prioritized druggable genes that are likely to be associated with Crohn’s disease pathogenesis, and our rank of candidate drugs successfully prioritized the Food and Drug Administration-approved drugs for Crohn’s disease. We also found literature evidence to support a number of drugs among the top 200 candidates. In summary, we demonstrated that a novel strategy combining unique disease phenotype data with system approaches can lead to rapid drug discovery. Availability and implementation: nlp.case.edu/public/data/DMN Contact: rxx@case.edu Oxford University Press 2015-06-15 2015-06-10 /pmc/articles/PMC4542779/ /pubmed/26072493 http://dx.doi.org/10.1093/bioinformatics/btv245 Text en © The Author 2015. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0/),which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Ismb/Eccb 2015 Proceedings Papers Committee July 10 to July 14, 2015, Dublin, Ireland Chen, Yang Li, Li Zhang, Guo-Qiang Xu, Rong Phenome-driven disease genetics prediction toward drug discovery |
title | Phenome-driven disease genetics prediction toward drug discovery |
title_full | Phenome-driven disease genetics prediction toward drug discovery |
title_fullStr | Phenome-driven disease genetics prediction toward drug discovery |
title_full_unstemmed | Phenome-driven disease genetics prediction toward drug discovery |
title_short | Phenome-driven disease genetics prediction toward drug discovery |
title_sort | phenome-driven disease genetics prediction toward drug discovery |
topic | Ismb/Eccb 2015 Proceedings Papers Committee July 10 to July 14, 2015, Dublin, Ireland |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542779/ https://www.ncbi.nlm.nih.gov/pubmed/26072493 http://dx.doi.org/10.1093/bioinformatics/btv245 |
work_keys_str_mv | AT chenyang phenomedrivendiseasegeneticspredictiontowarddrugdiscovery AT lili phenomedrivendiseasegeneticspredictiontowarddrugdiscovery AT zhangguoqiang phenomedrivendiseasegeneticspredictiontowarddrugdiscovery AT xurong phenomedrivendiseasegeneticspredictiontowarddrugdiscovery |